Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.
about
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis.Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.Waldenström's macroglobulinemia associated with serum amyloid A protein amyloidosis: pitfalls in diagnosis and successful treatment with melphalan-based autologous stem cell transplant.Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains.Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
P2860
Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current status of hematopoieti ...... yloid light-chain amyloidosis.
@en
Current status of hematopoieti ...... yloid light-chain amyloidosis.
@nl
type
label
Current status of hematopoieti ...... yloid light-chain amyloidosis.
@en
Current status of hematopoieti ...... yloid light-chain amyloidosis.
@nl
prefLabel
Current status of hematopoieti ...... yloid light-chain amyloidosis.
@en
Current status of hematopoieti ...... yloid light-chain amyloidosis.
@nl
P2093
P2860
P356
P1476
Current status of hematopoieti ...... myloid light-chain amyloidosis
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2011.152
P407
P577
2011-07-25T00:00:00Z